These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 34416977)

  • 21. AGA Clinical Practice Update on Management of Iron Deficiency Anemia: Expert Review.
    DeLoughery TG; Jackson CS; Ko CW; Rockey DC
    Clin Gastroenterol Hepatol; 2024 Jun; ():. PubMed ID: 38864796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AGA Clinical Practice Update on the Role of Artificial Intelligence in Colon Polyp Diagnosis and Management: Commentary.
    Samarasena J; Yang D; Berzin TM
    Gastroenterology; 2023 Dec; 165(6):1568-1573. PubMed ID: 37855759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An atlas of the nonpolypoid colorectal neoplasms in inflammatory bowel disease.
    Soetikno R; Sanduleanu S; Kaltenbach T
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):483-520. PubMed ID: 24975538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AGA Clinical Practice Update on Management of Ostomies: Commentary.
    Hedrick TL; Sherman A; Cohen-Mekelburg S; Gaidos JKJ
    Clin Gastroenterol Hepatol; 2023 Sep; 21(10):2473-2477. PubMed ID: 37498275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AGA Rapid Clinical Practice Update on the Management of Patients Taking GLP-1 Receptor Agonists Prior to Endoscopy: Communication.
    Hashash JG; Thompson CC; Wang AY
    Clin Gastroenterol Hepatol; 2024 Apr; 22(4):705-707. PubMed ID: 37944573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AGA Clinical Practice Update on Diagnosis and Management of Cyclic Vomiting Syndrome: Commentary.
    Levinthal DJ; Staller K; Venkatesan T
    Gastroenterology; 2024 Jul; ():. PubMed ID: 39023502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease.
    Toruner M; Harewood GC; Loftus EV; Sandborn WJ; Tremaine WJ; Faubion WA; Schroeder KW; Egan LJ
    Inflamm Bowel Dis; 2005 May; 11(5):428-34. PubMed ID: 15867581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AGA Clinical Practice Update on Endoscopic Full-Thickness Resection for the Management of Gastrointestinal Subepithelial Lesions: Commentary.
    D'Souza LS; Yang D; Diehl D
    Gastroenterology; 2024 Feb; 166(2):345-349. PubMed ID: 38108671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Case report: Colorectal dysplasia and cancer in IBD].
    Bulois P
    Gastroenterol Clin Biol; 2007 Apr; 31(4):412-4. PubMed ID: 17483779
    [No Abstract]   [Full Text] [Related]  

  • 30. Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments.
    Clarke WT; Feuerstein JD
    World J Gastroenterol; 2019 Aug; 25(30):4148-4157. PubMed ID: 31435169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveillance for dysplasia in patients with inflammatory bowel disease: a national survey of colonoscopic practice in New Zealand.
    Gearry RB; Wakeman CJ; Barclay ML; Chapman BA; Collett JA; Burt MJ; Frizelle FA
    Dis Colon Rectum; 2004 Mar; 47(3):314-22. PubMed ID: 14991493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases.
    Itzkowitz SH; Harpaz N
    Gastroenterology; 2004 May; 126(6):1634-48. PubMed ID: 15168373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Danish Society for Gastroenterology and Hepatology's clinical recommendations for colonoscopic surveillance for colorectal dysplasia and cancer in patients with inflammatory bowel disease.
    Ward D; Neumann A; Hendel JW; Riis LB; Tøttrup A; Jess T; Aalykke C
    Scand J Gastroenterol; 2022 Apr; 57(4):457-464. PubMed ID: 34968157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing Paradigms in Detection of Dysplasia and Management of Patients With Inflammatory Bowel Disease: Is Colectomy Still Necessary?
    Velayos F; Kathpalia P; Finlayson E
    Gastroenterology; 2017 Feb; 152(2):440-450.e1. PubMed ID: 27765687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ASGE Technology Committee systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting real-time endoscopic assessment of the histology of diminutive colorectal polyps.
    ; Abu Dayyeh BK; Thosani N; Konda V; Wallace MB; Rex DK; Chauhan SS; Hwang JH; Komanduri S; Manfredi M; Maple JT; Murad FM; Siddiqui UD; Banerjee S
    Gastrointest Endosc; 2015 Mar; 81(3):502.e1-502.e16. PubMed ID: 25597420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on Endoscopic Dysplasia Surveillance in Inflammatory Bowel Disease.
    Coelho-Prabhu N; Lewis JD
    Am J Gastroenterol; 2023 Oct; 118(10):1748-1755. PubMed ID: 37543741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].
    Angelberger S; Campregher C; Fuchssteiner H; Gasche C; Gröchenig HP; Haas T; Kazemi-Shirazi L; Mayer A; Miehsler W; Platzer R; Reinisch W; Steiner P; Tilg H; Tillinger W; Vogelsang H; Novacek G
    Z Gastroenterol; 2013 May; 51(5):450-7. PubMed ID: 23681899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?
    Moussata D; Allez M; Cazals-Hatem D; Treton X; Laharie D; Reimund JM; Bertheau P; Bourreille A; Lavergne-Slove A; Brixi H; Branche J; Gornet JM; Stefanescu C; Moreau J; Marteau P; Pelletier AL; Carbonnel F; Seksik P; Simon M; Fléjou JF; Colombel JF; Charlois AL; Roblin X; Nancey S; Bouhnik Y; Berger F; Flourié B;
    Gut; 2018 Apr; 67(4):616-624. PubMed ID: 28115492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A risk-profiling approach for surveillance of inflammatory bowel disease-colorectal carcinoma is more cost-effective: a comparative cost-effectiveness analysis between international guidelines.
    Lutgens M; van Oijen M; Mooiweer E; van der Valk M; Vleggaar F; Siersema P; Oldenburg B
    Gastrointest Endosc; 2014 Nov; 80(5):842-8. PubMed ID: 25088918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the pathologist in the diagnosis and treatment of dysplasia in inflammatory bowel disease.
    Berho M; Allende D
    J Gastrointest Surg; 2014 Jul; 18(7):1231-3. PubMed ID: 24671471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.